Lion Corporation (TYO:4912)
Japan · Delayed Price · Currency is JPY 1,894.00
-15.50 (-0.81%)
Aug 21, 2026, 3:30 PM JST
Lion Corporation Revenue
Lion Corporation had revenue of 117.63B JPY in the quarter ending June 30, 2026, with 11.79% growth. This brings the company's revenue in the last twelve months to 439.47B, up 6.21% year-over-year. In the year 2025, Lion Corporation had annual revenue of 422.09B with 2.22% growth.
Revenue (ttm)
439.47B
Revenue Growth
+6.21%
P/S Ratio
1.19
Revenue / Employee
52.66M
Employees
8,346
Market Cap
524.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 422.09B | 9.15B | 2.22% |
| Dec 31, 2024 | 412.94B | 10.18B | 2.53% |
| Dec 31, 2023 | 402.77B | 12.90B | 3.31% |
| Dec 31, 2022 | 389.87B | 23.64B | 6.45% |
| Dec 31, 2021 | 366.23B | 10.88B | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shiseido Company | 999.13B |
| Unicharm | 968.23B |
| Rohto Pharmaceutical | 353.39B |
| KOSE Holdings | 334.58B |
| Genky DrugStores | 220.64B |
| Earth | 185.57B |
| Pola Orbis Holdings | 171.38B |
| Kobayashi Pharmaceutical | 167.47B |
Lion Corporation News
- 10 days ago - Q2 2026 Lion Corp Earnings Presentation Transcript - GuruFocus